Cargando…
Mucormycosis in COVID-19 patients: predisposing factors, prevention and management
India is considered the diabetes capital of the world and has the highest burden of mucormycosis. Bacterial, viral and fungal co-infections are increasingly being reported in severe acute respiratory syndrome virus 2 (SARSCoV-2) infected patients. India is one of the worst affected countries during...
Autores principales: | Rudrabhatla, Pavan Kumar, Reghukumar, Aravind, Thomas, Sanjeev V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612391/ https://www.ncbi.nlm.nih.gov/pubmed/34820787 http://dx.doi.org/10.1007/s13760-021-01840-w |
Ejemplares similares
-
Predisposing factors of rhino-orbital-cerebral mucormycosis in patients with COVID 19 infection
por: Pradhan, Pradeep, et al.
Publicado: (2021) -
Hepatic failure and malnutrition as predisposing factors of cutaneous mucormycosis in a pediatric patient
por: Colman, Silvia, et al.
Publicado: (2021) -
Does Long-term Oxygen Therapy and Noninvasive Ventilation Predispose Rhino-orbital-cerebral Mucormycosis in COVID-19 Patients?
por: Kumar, Amarjeet, et al.
Publicado: (2022) -
COVID-19 Coinfection With Mucormycosis in a Diabetic Patient
por: R, Roopa, et al.
Publicado: (2021) -
Mucormycosis: A triple burden in patients with diabetes during COVID-19 Pandemic
por: Fathima, A.S., et al.
Publicado: (2021)